NWPF

News ArchivesRead News

Neupro improves motor, sleep, non-motor symptoms of PD in Recover study: UCB

Wednesday November 24, 2010

PBR - UCB's double-blind, randomised Recover study showed that treatment with Neupro (rotigotine) improved motor function, sleep and non-motor symptoms, compared to placebo, improving quality of life for people with Parkinson's disease (PD).

UCB claims that the Recover study is the first large-scale trial to investigate early morning motor function and sleep as coprimary outcome measures in Parkinson's disease (PD).

Data from the study showed that treatment with rotigotine improved both early morning motor function and nocturnal sleep disturbance compared with placebo.

Additionally, improvements were also seen with rotigotine in secondary and additional exploratory outcome measures related to sleep quality, pain, depression and activities of daily living.

University of Goettingen and Paracelsus-Elena Klinik, Kassel, Germany Neurology professor and Recover study investigator Claudia Trenkwalder said that the Recover study demonstrated benefits with rotigotine on each of these outcomes.

"It also demonstrated the clinical benefits of continuous rotigotine delivery, as efficacy was maintained throughout the night and into the next morning, and significantly improved the start of the new day, one of the most troubling times for PD patients,Trenkwalder said.

Recent News

Sep 19 - PD protein plays vital 'marshalling' role in healthy brains
Sep 14 - Is it Alzheimer's or another type of dementia?
Sep 13 - Stem cells injected into brain of patient
Sep 11 - Can yoga help Parkinson's patients?
Sep 8 - Can some types of fat protect us from brain disease?
Sep 8 - Common molecular mechanism of Parkinson's pathology discovered
Sep 6 - Virtual Reality Test Could Make It Easier To Diagnose MS And Parkinson’s
Sep 5 - Seattle hospital offers new treatment to stop shaking
Aug 29 - The Decline of Tube Feeding for Dementia Patients
Aug 28 - New test may help detect Parkinson's disease in early stages of illness
Aug 25 - Stealthy Biotech Revives Stalled Parkinson's Drug, Reveals Plans In Alzheimer's and ALS
Aug 22 - Parkinson's Disease Could Be Diagnosed Through Eye Check, Mice Help Researchers In Further Study
Aug 22 - Machine learning to unlock Parkinson's disease mystery
Aug 22 - Manufacturing Dopamine in the Brain with Gene Therapy
Aug 21 - Cognitive control plays major role in Parkinson’s Gait
Aug 15 - 'I've Never Felt Constrained': After Parkinson's Diagnosis, Chestnut Hill Man Turns To Drumming
Aug 11 - Virtual reality and treadmill training could help prevent falls in older adults
Aug 9 - New laboratory model replicates early phase of Parkinson's before onset of motor symptoms
Aug 8 - Marshall University Scientists Develop A New Approach For Parkinson’s Disease Therapy
Aug 5 - Cambuslang woman diagnosed with Parkinson's at 42 is set to trek through Alps